ALFERON N INJECTION

Serial Number 87399348
606

Registration Progress

Application Filed
Apr 5, 2017
Under Examination
Feb 13, 2018
Approved for Publication
Dec 19, 2017
Published for Opposition
Dec 19, 2017
Registered

Trademark Image

ALFERON N INJECTION

Basic Information

Serial Number
87399348
Filing Date
April 5, 2017
Published for Opposition
December 19, 2017
Abandonment Date
March 22, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 22, 2021
Classes
005

Rights Holder

AIM IMMUNOTECH INC.

03
Address
2117 SW HIGHWAY 484
OCALA, FL 34473

Ownership History

Hemispherx Biopharma, Inc.

Original Applicant
03
Philadelphia, PA

Hemispherx Biopharma, Inc.

Owner at Publication
03
Philadelphia, PA

AIM IMMUNOTECH INC.

New Owner After Publication #1
03
OCALA, FL

Legal Representation

Attorney
Donna J. Bunton

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

42 events
Date Code Type Description Documents
Mar 22, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 22, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 18, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 18, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 13, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 13, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 7, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 9, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 15, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 13, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 13, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 15, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 13, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 13, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 12, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 13, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 19, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 19, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 29, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 16, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 13, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 6, 2017 ALIE A ASSIGNED TO LIE Loading...
Oct 25, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 27, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 27, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 12, 2017 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Apr 11, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Parenterally administered interferon for use in treating viral diseases and immunological disorders

Additional Information

Pseudo Mark
ALFERON IN INJECTION; ALFERON AND INJECTION

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INJECTION"